GGrantIndex
Sort

39,280 grants matching leukemia

Impact of Infection and Inflammation on Primitive Hematopoiesis

$861,734
Katherine Yudeh King · Baylor College Of Medicine · R35 · FY2021 · HL

Cancer and Leukemia Group B - Leukemia Correlative Sciences

$861,611
Michael A Caligiuri · Ohio State University · U10 · FY2009 · CA

Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer

$861,520
Sunita K Patel · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA

Impact of Infection and Inflammation on Primitive Hematopoiesis

$861,418
Katherine Yudeh King · Baylor College Of Medicine · R35 · FY2023 · HL

Impact of Infection and Inflammation on Primitive Hematopoiesis

$861,418
Katherine Yudeh King · Baylor College Of Medicine · R35 · FY2025 · HL

Epstein-Barr Virus Associated Disorders

$861,221
Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Aerosolized Epigenetic Therapy for Metastatic Lung Cancer

$861,087
Matthew Reed · Nob Hill Therapeutics, Inc. · R44 · FY2023 · CA

PRCC/MDACC: Partners for Excellence in Cancer Research

$861,010
Gabriel Lopez-Berestein · University Of Tx Md Anderson Can Ctr · U54 · FY2006 · CA

Viral priming and targeting NK cells against solid tumor malignancies

$860,921
Jeffrey S Miller · University Of Minnesota · R35 · FY2019 · CA

PRCC/MDACC: Partners for Excellence in Cancer Research

$860,788
University Of Texas Md Anderson Can Ctr · U54 · FY2005 · CA

Molecular pathogenesis and therapy innovation for Merkel cell carcinoma

$860,577
Isaac Brownell · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Clinical Trials with Immunotoxins

$860,104
Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Studies of Atomic Bomb Survivors

$860,011
Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA

SPORE in Myeloid Malignancies

$859,786
Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2018 · CA

Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing

$859,730
Jesse J Salk · Twinstrand Biosciences, Inc. · R44 · FY2021 · CA

ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)

$859,607
Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2020 · CA

BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma

$859,480
Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA

Core C - Sequencing and Analysis.

$859,287
Christopher A Miller · Washington University · P01 · FY2020 · CA

Training Program in Molecular Hematology

$859,110
Nancy Berliner · Brigham And Women'S Hospital · T32 · FY2024 · HL

Protein Structure, Stability, and Amyloid Formation

$858,816
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

COGNITIVE REMEDIATION FOR CHILDHOOD CANCER SURVIVORS

$858,260
Oregon Health And Science University · R01 · FY2001 · CA

Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells

$857,707
James Even Voss · Scripps Research Institute, The · R01 · FY2025 · AI

Studies of Populations Exposed to Occupational Sources of Radiation

$857,152
Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

Minority Based Community Clinical Oncology Program

$857,043
University Of Illinois At Chicago · U10 · FY2004 · CA

Preventing GVHD by inhibition of alloantigen presentation in the gut

$856,395
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2023 · HL